SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-207767
Filing Date
2021-07-02
Accepted
2021-07-02 17:17:57
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d121988ds3.htm S-3 110175
2 EX-5.1 d121988dex51.htm EX-5.1 13164
3 EX-23.2 d121988dex232.htm EX-23.2 1750
4 GRAPHIC g121988dsp24.jpg GRAPHIC 3997
5 GRAPHIC g121988dsp25.jpg GRAPHIC 1957
6 GRAPHIC g121988dsp4.jpg GRAPHIC 3956
  Complete submission text file 0001193125-21-207767.txt   140271
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257687 | Film No.: 211071506
SIC: 2834 Pharmaceutical Preparations